Protein Forest has announced that Children's Hospital Boston has recently installed the digital Proteomechip system (DPC) to use in a study.
The study is entitled 'Multi-disciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network (U01) Discovery Site'.
It will be carried out in the laboratories of Keith Solomon, PhD, Richard Lee, MD, and Marsha Moses, under the direction of Hanno Steen, PhD.
Solomon's lab had been evaluating technologies to discover new biomarkers in urine and has selected the DPC system for this study.
The ability to identify new potential biomarkers, the greater reproducibility, faster analysis and ease of use were critical factors in selecting the DPC platform for this study.
The Proteomechip system fractionates and concentrates proteins or peptides by parallel isoelectric focusing in 30 minutes for superior mass spec analysis.
Additionally, pI information from the DPC prefractionation enables rapid discovery of post-translational modification-based biomarkers.
'We anticipate that the DPC technology and MSrat software will speed discovery time resulting in identification of potential biomarkers at one third of the time required by standard technologies,' said Keith Solomon.
